Companies that raised dividends last week (12/9/24 to 12/13/24)

Companies that raised dividends last week:

$LINE Lineage Inc: 38.8%
$RCL Royal Caribbean Cruises: 37.5%
$TGLS Tecnoglass Inc: 36.4%
$ZTS Zoetis Inc: 16%
$LLY Eli Lilly And Co: 15.4%
$AVGO Broadcom Inc: 11.3%
$MDLZ MONDELEZ INTERNATIONAL: 10.6%
$BCPC Balchem Corp: 10.1%
$ABT Abbott Laboratories: 7.3%
$WDFC WD-40 Co: 6.8%
$SEIC SEI Investments Co: 6.5%
$EIX Edison International: 6.1%
$RWT Redwood Trust Inc: 5.9%
$AMGN Amgen Inc: 5.8%
$TTC Toro Co: 5.6%
$SYK Stryker Corp: 5%
$ENSG Ensign Group Inc: 4.2%
$INVH Invitation Homes Inc: 3.6%
$BMY Bristol-Myers Squibb Co: 3.3%
$MAA Mid-America Apartment: 3.1%
$ANDE Andersons Inc: 2.6%
$PFE Pfizer Inc: 2.4%
$NUE Nucor Corp: 1.9%
$EPRT Essential Properties Realty: 1.7%
$ARE Alexandria Real Estate Equities: 1.5%
$O Realty Income Corp: 0.2%

This animal healthcare stocks is fairly valued

Zoetis is the largest global animal health company, holding a significant market share. Its strong brand recognition and extensive portfolio of products for livestock and pets give it a competitive edge. Zoetis has demonstrated strong and consistent financial performance, with steady revenue and profit growth. This stability is attractive for long-term investors seeking reliable returns. Zoetis offers a wide range of products including vaccines, medicines, diagnostics, and genetic tests for both livestock and companion animals. This diversification helps mitigate risk and ensures multiple revenue streams. The pet care market has been growing steadily, driven by increasing pet ownership and higher spending on pet health and wellness. Zoetis is well-positioned to benefit from this trend with its extensive range of pet health products. Zoetis invests heavily in research and development, continuously bringing new and innovative products to market. This focus on innovation helps maintain its competitive edge and drives future growth. Zoetis has a strong international presence and continues to expand into new markets, particularly in emerging economies where demand for animal health products is increasing. The company has a history of strategic acquisitions that enhance its product offerings and market reach. These acquisitions help drive growth and improve the company's competitive position. Zoetis is committed to sustainable business practices, which can enhance its reputation and appeal to socially responsible investors. This includes efforts in environmental sustainability and ethical animal treatment. The animal health industry tends to be more resilient during economic downturns compared to other sectors, as spending on animal health is often considered essential. This stability can provide a buffer against economic volatility. Zoetis has a strong and experienced management team with a clear vision for long-term growth and value creation. Effective leadership is crucial for navigating challenges and capitalizing on opportunities.

$ZTS - Zoestis, an animal healthcare company looks fairly valued. 

PE ratio: 29.65

Dividend Payout ratio: 29.98%

FCF payout ratio: 49.29%

5 yr revenue CAGR: +7.96%

5 yr EPS CAGR: +11.41%

5 yr FCF CAGR: +3.18%

5 yr dividend CAGR: +24.37%

FCF yield: 2.05%

FCF margin: 18.94%

12 months Analyst avg. price target: $209.33 (22.35% upside)

$ZTS: Since 2010, the EPS has been growing by double digits.

5 yr EPS CAGR: +11.41%

10 yr EPS CAGR: +17.53%

EPS growth forecast for 

2024: +14.82% (19 analysts)

2025: +10.67% (19 analysts)

2026: +9.71% (14 analysts)

$ZTS: Since 2010, the revenue has been growing.

5 yr revenue CAGR: +7.96%

10 yr revenue CAGR: +6.48%

Revenue growth forecast for

2024: +8.19% (19 analysts)

2025: +6.17% (19 analysts)

2026: +6.61% (14 analysts)

$ZTS - The net income has been growing by double digits. 5 yr net income CAGR: +10.42% 10 yr net income CAGR: +16.61% Net income is increasing while the outstanding shares are decreasing which indicates a positive financial trend for the company, leading to an increase in EPS and share buybacks.

$ZTS - The debt-to-equity is dropping fast.

$ZTS - so far is an outstanding dividend grower. 5 yr dividend CAGR: +24.37% 10 yr dividend CAGR: +22.63% Dividend Payout ratio: 29.98% FCF payout ratio: 49.29%

The companies that raised its dividends from January 22 to 26, 2024

 Below are the companies that raised their dividends last week.

#CINF #SJW #BKH #KMB #SPGI #APD #ADM #FELE #NI #YUM #CMCSA #AXP #BX

Dividend increases announced from November 27 to December 1, 23

 The companies that increased their dividend this week. $MKC a dividend champion increased by 7.7%. Three dividend achievers $GGG, $MRK, and $COFC also increased by 8.5%, 5.5%, and 3.8% respectively. 

Recent Dividend Increases

 Recently Kroger’s $KR raises the dividend by 11.5%. The yield is 2.5%, PE is 14.46, and the payout ratio is 32.6%.

General Mills’ $GIS raises the dividend by 9.3%. The yield is 2.82%, PE is 18.09, and the payout ratio is 50.94%.

Goldman Sachs raises the dividend by 10%. The FWD yield is 3.1%, PE is 10.65, and the payout ratio is 33.01%. 5 yr CAGR is 26.81%, A great dividend growth company.

Dividends

Dividend Investing

Dividend Stocks

Dividend Income

Opened a new position in Medtronics (MDT)

Medtronics ($MDT)

    Yesterday I have opened a new position in Medtronics ($MDT). It is a dividend aristocrat, raising dividends for the last 45 years. They are down 32% from 52 weeks high with a PE ratio of 14. The payout ratio is only 23%. 

The company is a $109 billion dollar medical device company. It's a buy for me for longer term.

I have purchased 15 shares at $77.57. Each share gives $2.72 annually in dividends and I will receive $30 yearly in dividends from this purchase.

    Its 5 year CAGR is 8% which is pretty good and because of its low payout ratio there are plenty of rooms to increase the dividends in the future.

My projected dividend growth since 2017

    Hello all, I am sharing my projected yearly income form dividends. I have started to invest in 2017. Since then I am investing in dividend paying stocks. The advantage of dividend investing is that I will have yearly income from my investment which I am reinvesting to grow my wealth and every company increase their dividends yearly. So more yearly income, more stocks, and more dividends.

    The above figure shows my current yearly income from dividends. In 2017, I had no income from dividends and now in 5 years I am earning $2,408 yearly. 

    The above figure shows how my income increased since 2017. There is a big drop in 2020 as I had to sell some shares to finance my first home. 

    The above chart shows my dividend income monthly in the last 5 years. You can clearly see that my income is keep increasing yearly. The simplest rule is to reinvest the dividends and keep addning more stocks monthly.

    The above figure shows my quarterly income since 2018. In 2018, I was earning only $100 per quarter and in 2022 I am earning more than $400 quarterly which is more than 4 times.